Evidence map›Paper›PMID 9600997›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1998

Muscarinic cholinergic regulation of cardiac myocyte ICa-L is absent in mice with targeted disruption of endothelial nitric oxide synthase.

X Han, I Kubota, O Feron, D J Opel, M A Arstall, Y Y Zhao, P Huang, M C Fishman, T Michel, R A Kelly

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 143 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Cardiac sympatho-vagal balance and ventricular arrhythmia.Autonomic neuroscience : basic & clinical · 2016
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. The exercising heart at altitude.Cellular and molecular life sciences : CMLS · 2009
    Review
  11. Nitric oxide signaling and the regulation of myocardial function.Journal of molecular and cellular cardiology · 2008
    Review
  12. Article
  13. Article
  14. Article
  15. Nitric oxide control of cardiac function: is neuronal nitric oxide synthase a key component?Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2004
    Review
  16. Article
  17. Article
  18. Muscarinic regulation of cardiac ion channels.British journal of pharmacology · 2003
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

X HanCardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA.
I Kubota
O Feron
D J Opel
M A Arstall
Y Y Zhao
P Huang
M C Fishman
T Michel
R A Kelly
Harvard University · USBrigham and Women's Hospital · USMassachusetts General Hospital · US

Funding

THE NO PATHWAY AND REGULATION OF MYOCARDIAL FUNCTIONP50HL052320 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SEIDMAN, CHRISTINE E. · 1995 to 2004
$7.8M
NHLBI NIH HHS HL52320NHLBI NIH HHS P50 HL052320
6 · The paper itself

Abstract

Cardiac myocytes have been shown to express constitutively endothelial nitric oxide synthase (eNOS) (nitric oxide synthase 3), the activation of which has been implicated in the regulation of myocyte L-type voltage-sensitive calcium channel current (ICa-L) and myocyte contractile responsiveness to parasympathetic nervous system signaling, although this implication remains controversial. Therefore, we examined the effect of the muscarinic cholinergic agonist carbachol (CCh) on ICa-L and contractile amplitude in isoproterenol (ISO)-prestimulated ventricular myocytes isolated from adult mice, designated eNOSnull mice, with targeted disruption of the eNOS gene. Although both eNOSnull and wild-type (WT) ventricular myocytes exhibited similar increases in ICa-L in response to ISO, there was no measurable suppression of ICa-L by CCh in cells from eNOSnull mice, in contrast to cells from WT mice. These results were reflected in the absence of an effect of CCh on the positive inotropic effect of ISO in eNOSnull myocytes. Also, unlike myocytes from WT animals, eNOSnull myocytes failed to exhibit an increase in cGMP content in response to CCh. Nevertheless, the pharmacologic nitric oxide donors 3-morpholino-sydnonimine and S-nitroso-acetyl-cystein increased cGMP generation and suppressed ISO-augmented ICa-L in eNOSnull cells, suggesting that the signal transduction pathway(s) downstream of eNOS remained intact. Of importance, activation of the acetylcholine-activated K+ channel by CCh was unaffected in atrial and ventricular eNOSnull myocytes. These results confirm the obligatory role of eNOS in coupling muscarinic receptor activation to cGMP-dependent control of ICa-L in cardiac myocytes.

Indexed as

AnimalsCalcium ChannelsCarbacholCells, CulturedGene Expression RegulationHeartMiceMice, KnockoutMuscarinic AgonistsMyocardial ContractionMyocardiumNitric Oxide SynthaseReceptors, MuscarinicCalcium ChannelsCarbacholMuscarinic AgonistsNitric Oxide SynthaseReceptors, Muscarinic

Identifiers

PMID9600997
PMCPMC27837
OpenAlexW1973003784

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.